4//SEC Filing
Pestano Gary Anthony 4
Accession 0000905148-25-000527
CIK 0001439725other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 5:12 PM ET
Size
13.4 KB
Accession
0000905148-25-000527
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Pestano Gary Anthony
Chief Development Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-10−28,256→ 56,510 total→ Common Stock (28,256 underlying) - Exercise/Conversion
Common Stock
2025-02-10+45,729→ 172,756 total - Sale
Common Stock
2025-02-11$0.92/sh−16,748$15,479→ 156,008 total - Exercise/Conversion
Restricted Stock Units
2025-02-10−1,378→ 5,513 total→ Common Stock (1,378 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-10−16,095→ 48,286 total→ Common Stock (16,095 underlying)
Footnotes (6)
- [F1]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F3]The price reported in Column 4 is a weighted average price of all shares sold on the transaction date by the Issuer's broker to cover taxes upon the vesting of RSUs for certain employees of the Issuer, including the Reporting Person. These shares were sold in multiple transactions at prices ranging from $0.90 to $0.9536, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
- [F5]These RSUs vest in a series of four successive equal annual installments measured from February 8, 2023, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
- [F6]These RSUs vest in a series of four successive equal annual installments measured from January 15, 2024, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001827711
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 5:12 PM ET
- Size
- 13.4 KB